Precise | Efficient | Stable
Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death world- wide in 2020......Learn more
Thyroid cancer is responsible for 586,000 cases worldwide, ranking in 9th place for incidence in 2020. The global incidence rate in women of......Learn more
Kidney cancer is currently the ninth most common cancer in men and the 14th most common in women worldwide. An estimated 431,288 people were......Learn more
Canyon Medical made the debut at Endo Dubai from Feb 23rd to 25th, delightedly showcasing microwave ablation as the latest developments and innovations to manage treatment minimal invasively.Prof. Xia...Learn more
Partner with Med-Italia Biomedica, Canyon has the pleasure to attend MITT and SYT Save Your Thyroid scheduled on 15-16 Feb in Milan. It is a productive and inspiring period of time by listening a...Learn more
For four intense days at our booth, where Canyon and SurgMate, are welcoming visitors non-stop, engaging closely with our valued medicare professionals and partners, and showcasing the latest dev...Learn more
Canyon exhibited for the first time at SIRS2023 Riyadh, showcasing our cutting-edge Microwave Ablation generator as well as a whole portfolio of antennas for better solutions!The workshop is buzz...Learn more
Canyon Medical Inc., back in 1986, is leading, pioneering, and specializing in the R&D, manufacturing, sales & marketing of microwave ablation over 30 years. By collaborating with research institutes and healthcare professionals to solve clinical request and challenges, we are proud to be the exceptional and prominent contributor in terms of the education and spreading of microwave ablation technology and solutions home and abroad.
In China, Canyon microwave ablation device has benefited over 300,000 patients, and saved their families! In addition, we are expanding its business operations in over 40 countries and regions around the world, providing the best possible products and solutions globally. A huge burst of interest and excitement are being ignited for such a safe and effective minimal invasive treatment for solid tumors, and benign lesions!
Patents for invention
Patents for utility model/industrial design
Class 10,000 clean room
Ratio of R&D personnel
Ratio of R&D investment